Does difference between label and actual potency of factor VIII concentrate affect pharmacokinetic-guided dosing of replacement therapy in haemophilia A?
- Tine M.H.J. Goedhart
- , Laura H. Bukkems
- , the OPTI-CLOT study group and SYMPHONY consortium
- , Iris van Moort
- , Colin C. Spence
- , Michel C. Zwaan
- , Moniek P.M. de Maat
- , Ron A.A. Mathôt
- , Marjon H. Cnossen*
*Corresponding author for this work
Research output: Contribution to journal › Article › Academic › peer-review
1
Citation
(Scopus)
66
Downloads
(Pure)